Hepatobiliary Surgery and Liver Transplantation Service, Saint Antoine Hospital, Assistance Public-Hôpitaux de Paris, Paris, France.
Liver Transpl. 2012 Apr;18(4):413-22. doi: 10.1002/lt.22479.
Split liver transplantation (SLT) using extended right grafts is associated with complications related to ischemia of hepatic segment 4 (S4), and these complications are associated with poor outcomes. We retrospectively analyzed 36 SLT recipients so that we could assess the association of radiological, biological, and clinical features with S4 ischemia. The overall survival rates were 84.2%, 84.2%, and 77.7% at 1, 3, and 5 years, respectively. The recipients were mostly male (24/36 or 67%) and had a median age of 52 years (range = 13-63 years), a median body mass index of 22.9 kg/m(2) (range = 17.3-29.8 kg/m(2) ), and a median graft-to-recipient weight ratio of 1.3% (range = 0.9%-1.9%). S4-related complications were diagnosed in 22% of the patients (8/36) with a median delay of 22 days (range = 10-30 days). Secondary arterial complications were seen in 3 of these patients and led to significantly decreased graft survival in comparison with the graft survival of patients without complications (50.0% versus 85.6%, P = 0.017). Patients developing S4-related complications had significantly elevated aspartate aminotransferase (AST) levels (>1000 IU/L) on postoperative day (POD) 1 and elevated gamma-glutamyl transpeptidase (GGT) levels (>300 IU/L) on PODs 7 and 10 (P < 0.05). These AST and GGT elevations conferred a significantly high risk of developing these complications (odds ratio = 42, 95% confidence interval = 4-475, P < 0.05). The ischemic volume of S4 was extremely variable (0%-95%) and did not correlate with S4-related complications. In conclusion, our results suggest that S4-related complications are risk factors for worse graft survival, and the development of these complications can be anticipated by the early identification of a specific biological profile and a routine radiological examination.
劈离式肝移植(SLT)采用扩展右移植物与肝段 4(S4)缺血相关的并发症相关,这些并发症与不良预后相关。我们回顾性分析了 36 例 SLT 受者,以评估 S4 缺血与影像学、生物学和临床特征的关系。总体生存率分别为 1、3 和 5 年的 84.2%、84.2%和 77.7%。受者主要为男性(24/36 或 67%),中位年龄为 52 岁(范围=13-63 岁),中位体重指数为 22.9kg/m2(范围=17.3-29.8kg/m2),中位供体与受体体重比为 1.3%(范围=0.9%-1.9%)。22%(8/36)的患者诊断为 S4 相关并发症,中位延迟时间为 22 天(范围=10-30 天)。其中 3 例患者出现继发性动脉并发症,与无并发症患者的移植物存活率相比,明显降低(50.0%比 85.6%,P=0.017)。发生 S4 相关并发症的患者术后第 1 天天冬氨酸转氨酶(AST)水平(>1000IU/L)和第 7 天和第 10 天γ-谷氨酰转肽酶(GGT)水平(>300IU/L)明显升高(P<0.05)。这些 AST 和 GGT 升高显著增加了发生这些并发症的风险(比值比=42,95%置信区间=4-475,P<0.05)。S4 的缺血体积变化极大(0%-95%),与 S4 相关并发症无关。总之,我们的结果表明,S4 相关并发症是移植物存活率下降的危险因素,通过早期识别特定的生物学特征和常规影像学检查,可以预测这些并发症的发生。